BioCentury
ARTICLE | Company News

Europe approves BTRN cell separation product

July 26, 2002 7:00 AM UTC

BioTransplant (BTRN) received European CE Mark approval for its Eligix CD8-SC cell separation technology to separate CD8+ T cells from donor stem cells for transplant. The system is indicated for ex v...